Lixte Biotechnology Holdings Inc (LIXTW) — Financial Flexibility Index
Lixte Biotechnology Holdings Inc (LIXTW) has a Financial Flexibility Index of -1.78x as of September 2025. Free cash flow of $-926.75K (operating CF $-926.75K minus capex $2.00) represents -2% of total liabilities ($521.42K). Check asset resilience ratio of Lixte Biotechnology Holdings Inc to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lixte Biotechnology Holdings Inc Financial Flexibility Index (2005–2024)
Historical Financial Flexibility Index trend for Lixte Biotechnology Holdings Inc across 20 annual periods. See LIXTW net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Lixte Biotechnology Holdings Inc (2005–2024)
Year-by-year free cash flow to debt coverage for Lixte Biotechnology Holdings Inc. For the full company profile including market capitalisation, see LIXTW market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -9.94x | $-3.16 Million | $-3.16 Million | $318.28K | ▲ +27.3% |
| 2023 | -13.68x | $-4.29 Million | $-4.29 Million | $313.86K | ▼ -17.1% |
| 2022 | -11.68x | $-4.61 Million | $-4.61 Million | $394.79K | ▲ +14.6% |
| 2021 | -13.68x | $-4.14 Million | $-4.14 Million | $302.93K | ▼ -38.9% |
| 2020 | -9.84x | $-2.13 Million | $-2.13 Million | $216.52K | ▼ -39.9% |
| 2019 | -7.04x | $-1.67 Million | $-1.67 Million | $237.90K | ▲ +1.8% |
| 2018 | -7.16x | $-1.51 Million | $-1.51 Million | $210.91K | ▼ -89.2% |
| 2017 | -3.79x | $-1.41 Million | $-1.41 Million | $373.02K | ▲ +50.7% |
| 2016 | -7.67x | $-1.68 Million | $-1.68 Million | $218.65K | ▼ -0.5% |
| 2015 | -7.64x | $-2.18 Million | $-2.18 Million | $285.64K | ▼ -27.7% |
| 2014 | -5.98x | $-1.64 Million | $-1.64 Million | $273.44K | ▼ -63.1% |
| 2013 | -3.67x | $-1.18 Million | $-1.18 Million | $321.77K | ▲ +20.6% |
| 2012 | -4.62x | $-1.21 Million | $-1.21 Million | $261.15K | ▼ -19.1% |
| 2011 | -3.88x | $-1.36 Million | $-1.36 Million | $350.75K | ▲ +19.2% |
| 2010 | -4.80x | $-936.39K | $-936.39K | $195.06K | ▼ -125.8% |
| 2009 | -2.13x | $-638.44K | $-638.44K | $300.26K | ▼ -33.5% |
| 2008 | -1.59x | $-597.69K | $-597.69K | $375.20K | ▲ +42.8% |
| 2007 | -2.79x | $-702.60K | $-702.87K | $252.18K | ▲ +21.7% |
| 2006 | -3.56x | $-442.95K | $-443.45K | $124.50K | ▼ -35.3% |
| 2005 | -2.63x | $-32.87K | $-32.87K | $12.50K | — |